ロード中...
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
PURPOSE: Pre-clinical models have demonstrated the benefit of metronomic schedules of cytotoxic chemotherapy combined with anti-angiogenic compounds. This trial was undertaken to determine the toxicity of a low dose regimen using docetaxel and thalidomide. PATIENTS AND METHODS: Patients with advance...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4209291/ https://ncbi.nlm.nih.gov/pubmed/18470481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-008-9137-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|